 <h1>Prograf Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>tacrolimus</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about tacrolimus. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Prograf.</p><h2>In Summary</h2><p><b>Common side effects of Prograf include:</b> opportunistic infection, diabetes mellitus, infection, headache, hyperglycemia, hyperkalemia, increased blood urea nitrogen, increased serum creatinine, mental status changes, nephrotoxicity, sensation disorder, and tremor.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to tacrolimus: oral capsule, oral capsule extended release, oral granule, oral tablet extended release</i></p><p>Other dosage forms:</p><ul><li>intravenous solution</li></ul><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Capsule, Extended Release; Capsule; Granule)</p><p>Increased risk for developing serious infections and malignancies with tacrolimus extended-release or other immunosuppressants that may lead to hospitalization or death. Increased mortality in female liver transplant patients with tacrolimus extended-release; not approved for use in liver transplantation.Increased risk for developing serious infections and malignancies with tacrolimus oral capsules, oral granules, or other immunosuppressants that may lead to hospitalization or death.</p><p class="blackboxWarning-title">Oral route (Tablet, Extended Release)</p><p>Increased risk for developing serious infections and malignancies with tacrolimus extended-release tablets or other immunosuppressants that may lead to hospitalization or death.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, tacrolimus (the active ingredient contained in Prograf) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking tacrolimus:</p><p>
<i>More common</i>
</p><ul>
<li>Abnormal dreams</li>
<li>agitation</li>
<li>chills</li>
<li>confusion</li>
<li>cough</li>
<li>diarrhea</li>
<li>dizziness</li>
<li>fever</li>
<li>frequent urination</li>
<li>general feeling of discomfort or illness</li>
<li>headache</li>
<li>itching, skin rash</li>
<li>joint pain</li>
<li>loss of appetite</li>
<li>loss of energy or weakness</li>
<li>mental depression</li>
<li>muscle pains, trembling, or twitching</li>
<li>nausea</li>
<li>pale skin</li>
<li>runny nose</li>
<li>seeing or hearing things that are not there</li>
<li>seizures</li>
<li>shivering</li>
<li>sore throat</li>
<li>stomach pain</li>
<li>swelling of the feet or lower legs</li>
<li>tingling</li>
<li>trembling and shaking of the hands</li>
<li>trouble sleeping</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Blurred vision</li>
<li>chest pain</li>
<li>increased sensitivity to pain</li>
<li>muscle cramps</li>
<li>numbness or pain in the legs</li>
<li>ringing in the ears</li>
<li>sweating</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Enlarged heart</li>
<li>flushing of the face or neck</li>
<li>weight loss</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Black, tarry stools</li>
<li>blistering, peeling, or loosening of the skin</li>
<li>bloating</li>
<li>bloody urine</li>
<li>constipation</li>
<li>drowsiness</li>
<li>fainting</li>
<li>fast, slow, or irregular heartbeat</li>
<li>heartburn</li>
<li>increased thirst</li>
<li>indigestion</li>
<li>joint pain</li>
<li>lightheadedness</li>
<li>lower back or side pain</li>
<li>pinpoint red spots on the skin</li>
<li>pounding or rapid pulse</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>skin sores</li>
<li>ulcers or white spots in the mouth or on the lips</li>
<li>weakness</li>
<li>weight gain</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of tacrolimus may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Belching</li>
<li>difficulty with moving</li>
<li>lack or loss of strength</li>
<li>muscle stiffness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Body aches or pain</li>
<li>burning or stinging of the skin</li>
<li>cracks in the skin</li>
<li>crying</li>
<li>dysphoria</li>
<li>excessive muscle tone</li>
<li>false beliefs that cannot be changed by facts</li>
<li>false or unusual sense of well-being</li>
<li>feeling of constant movement of self or surroundings</li>
<li>feeling of unreality</li>
<li>feeling that others are watching you or controlling your behavior</li>
<li>feeling that others can hear your thoughts</li>
<li>increased sensitivity of the skin to sunlight</li>
<li>large, flat, blue or purplish patches in the skin</li>
<li>muscle tension or tightness</li>
<li>painful blisters on the trunk of the body</li>
<li>painful cold sores or blisters on the lips, nose, eyes, or genitals</li>
<li>paranoia</li>
<li>poor insight and judgment</li>
<li>problems with memory or speech</li>
<li>quick to react or overreact emotionally</li>
<li>rapidly changing moods</li>
<li>redness or other discoloration of the skin</li>
<li>restlessness</li>
<li>scaly skin</li>
<li>sensation of spinning</li>
<li>sense of detachment from self or body</li>
<li>severe mood or mental changes</li>
<li>severe sunburn</li>
<li>sleepiness or unusual drowsiness</li>
<li>sore mouth or tongue</li>
<li>sores on the skin</li>
<li>swelling or inflammation of the mouth</li>
<li>tender, swollen glands in the neck</li>
<li>trouble recognizing objects</li>
<li>trouble thinking and planning</li>
<li>trouble walking</li>
<li>unusual behavior</li>
<li>white patches in the mouth, tongue, or throat</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Change in color vision</li>
<li>decreased weight</li>
<li>difficulty seeing at night</li>
<li>feeling hot and cold</li>
<li>hearing loss</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tacrolimus: intravenous solution, oral capsule, oral capsule extended release, oral granule for reconstitution, oral tablet extended release</i></p><h3>General</h3><p>Some of the most commonly reported side effects include hypertension, diarrhea, hyperglycemia, anemia, headache, tremor, insomnia, pain, and asthenia.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (89%), peripheral edema (36%), chest pain (19%), pericardial effusion (15%)</p>
<p><b>Frequency not reported</b>: Angina pectoris, bradycardia, cardiac fibrillation, cardiomyopathy, cardiopulmonary failure, deep thrombophlebitis, ECG abnormalities, echocardiogram abnormalities, heart rate decreased, hemorrhage, hypotension, myocardial hypertrophy, peripheral vascular disorder, phlebitis, tachycardia, thrombosis, vasodilation</p>
<p><b>Postmarketing reports</b>: Cardiac arrest, myocardial infarction, ventricular fibrillation, congestive cardiac failure, pericardial effusion, supraventricular extrasystoles, supraventricular tachycardia, bradycardia, Torsade de Pointes, QT prolongation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (72%), nausea (46%), constipation (36%), vomiting (29%), dyspepsia (28%)</p>
<p><b>Frequency not reported</b>: Abdomen enlarged, duodenitis, dysphagia, esophagitis, flatulence, gastritis, gastroesophagitis, GI hemorrhage, GI perforation, ileus, oral moniliasis, pancreatic pseudocyst, peritonitis, rectal disorder, stomatitis, ulcerative esophagitis, ulcer<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hyperglycemia (70%), hypophosphatemia (49%), hypomagnesemia (48%), hyperkalemia (45%), anorexia (34%), hyperlipidemia (34%), hypokalemia (29%)</p>
<p><b>Frequency not reported</b>: Abnormal healing, acidosis, alkalosis, appetite increased, bicarbonate decreased, dehydration, gout, hypercalcemia, hypercholesterolemia, hyperphosphatemia, hyperuricemia, hypervolemia, hypocalcemia, hypoglycemia, hyponatremia, hypoproteinemia, lactic dehydrogenase increased, weight gain<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (65%), leukopenia (48%), leukocytosis (32%), thrombocytopenia (24%)</p>
<p><b>Frequency not reported</b>: Coagulation disorder, ecchymosis, hematocrit increased, hemoglobin abnormal, hypochromic anemia, polycythemia, prothrombin decreased, serum iron decreased</p>
<p><b>Postmarketing reports</b>: Agranulocytosis, disseminated intravascular coagulation, hemolytic anemia, hemolytic-uremic syndrome, neutropenia, pancytopenia, pure red cell aplasia, thrombocytopenic purpura, thrombotic thrombocytopenic purpura<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (64%), tremor (56%), paresthesia (40%), dizziness (19%), fatigue (16%)</p>
<p><b>Frequency not reported</b>: Amnesia, aphasia, convulsion, encephalopathy, hemorrhagic stroke, hypertonia, incoordination, monoparesis, myoclonus, nerve compression, nervousness, neuralgia, neuropathy, paralysis flaccid, psychomotor skills impaired, quadriparesis, seizures, somnolence, vertigo, writing impaired</p>
<p><b>Postmarketing reports</b>: Coma, dysarthria, posterior reversible encephalopathy syndrome (PRES), progressive multifocal leukoencephalopathy (PML), status epilepticus, quadriplegia, flaccid paralysis, hemiparesis, aphasia, syncope, carpal tunnel syndrome, nerve compression, mutism, dysarthria<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (64%) </p>
<p><b>Frequency not reported</b>: Abnormal dreams, agitation, anxiety, confusion, crying, depression, emotional lability, hallucinations, mental status changes, mood elevated, nightmares, psychosis, thinking abnormal</p>
<p><b>Postmarketing reports</b>: Mutism<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pain (63%), asthenia (54%), fever (48%)</p>
<p><b>Frequency not reported</b>: Abscess, accidental injury, chills, ear pain, fall, feeling abnormal, generalized edema, hernia, otitis media, sepsis, temperature intolerance, tinnitus<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Serum creatinine increased (45%), BUN increased (30%)</p>
<p><b>Frequency not reported</b>: BK nephropathy, hydronephrosis, renal failure, toxic nephropathy, tubular necrosis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Pleural effusion (36%), dyspnea (29%), atelectasis (28%), cough increased (18%), bronchitis (17%)</p>
<p><b>Frequency not reported</b>: Asthma, emphysema, hiccups, lung disorder, pharyngitis, pneumonia, pneumothorax, pulmonary edema, rhinitis, sinusitis, voice changes</p>
<p><b>Postmarketing reports</b>: Interstitial lung disease, pulmonary hypertension, lung infiltration, hiccups<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Liver function tests abnormal (36%)</p>
<p><b>Frequency not reported</b>: Cholangitis, cholestatic jaundice, GGT increased, granulomatous hepatitis, hepatitis, jaundice<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Pruritus (36%), rash (24%)</p>
<p><b>Frequency not reported</b>: Alopecia, cellulitis, hirsutism, photosensitivity, sweating</p>
<p><b>Postmarketing reports</b>: Hyperpigmentation<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract infection (34%), oliguria (19%)</p>
<p><b>Frequency not reported</b>: Albuminuria, bladder spasm, cystitis, dysuria, hematuria, nocturia, pyuria, urge incontinence, urinary frequency, urinary incontinence, urinary retention, vaginitis, hemorrhagic cystitis, urinary retention<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Cytomegalovirus infection (12%)</p>
<p><b>Frequency not reported</b>: Flu syndrome, graft versus host disease (acute and chronic)<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Postmarketing reports</b>: Epstein-Barr virus associated lymphoproliferative disorder, hepatosplenic T-cell lymphoma, leukemia, lymphoma, melanoma, post-transplant lymphoproliferative disorder (PTLD)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Arthralgia, generalized spasm, joint disorder, leg cramps, mobility decreased, myasthenia, myalgia, osteoporosis</p>
<p><b>Postmarketing reports</b>: Rhabdomyolysis, polyarthritis, pain in extremity including Calcineurin-Inhibitor Induced Pain Syndrome (CIPS)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity, Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Abnormal vision, amblyopia, blindness, optic atrophy, photophobia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Prograf (tacrolimus)." Fujisawa, Deerfield, IL. </p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Prograf (tacrolimus)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>26 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: calcineurin inhibitors</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Prograf &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Prograf Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Envarsus XR, Astagraf XL, Hecoria</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Organ Transplant, Rejection Reversal</li>
<li>Organ Transplant, Rejection Prophylaxis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tacrolimus: intravenous solution, oral capsule, oral capsule extended release, oral granule for reconstitution, oral tablet extended release</i></p><h3>General</h3><p>Some of the most commonly reported side effects include hypertension, diarrhea, hyperglycemia, anemia, headache, tremor, insomnia, pain, and asthenia.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (89%), peripheral edema (36%), chest pain (19%), pericardial effusion (15%)</p><p><b>Frequency not reported</b>: Angina pectoris, bradycardia, cardiac fibrillation, cardiomyopathy, cardiopulmonary failure, deep thrombophlebitis, ECG abnormalities, echocardiogram abnormalities, heart rate decreased, hemorrhage, hypotension, myocardial hypertrophy, peripheral vascular disorder, phlebitis, tachycardia, thrombosis, vasodilation</p><p><b>Postmarketing reports</b>: Cardiac arrest, myocardial infarction, ventricular fibrillation, congestive cardiac failure, pericardial effusion, supraventricular extrasystoles, supraventricular tachycardia, bradycardia, Torsade de Pointes, QT prolongation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (72%), nausea (46%), constipation (36%), vomiting (29%), dyspepsia (28%)</p><p><b>Frequency not reported</b>: Abdomen enlarged, duodenitis, dysphagia, esophagitis, flatulence, gastritis, gastroesophagitis, GI hemorrhage, GI perforation, ileus, oral moniliasis, pancreatic pseudocyst, peritonitis, rectal disorder, stomatitis, ulcerative esophagitis, ulcer<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hyperglycemia (70%), hypophosphatemia (49%), hypomagnesemia (48%), hyperkalemia (45%), anorexia (34%), hyperlipidemia (34%), hypokalemia (29%)</p><p><b>Frequency not reported</b>: Abnormal healing, acidosis, alkalosis, appetite increased, bicarbonate decreased, dehydration, gout, hypercalcemia, hypercholesterolemia, hyperphosphatemia, hyperuricemia, hypervolemia, hypocalcemia, hypoglycemia, hyponatremia, hypoproteinemia, lactic dehydrogenase increased, weight gain<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (65%), leukopenia (48%), leukocytosis (32%), thrombocytopenia (24%)</p><p><b>Frequency not reported</b>: Coagulation disorder, ecchymosis, hematocrit increased, hemoglobin abnormal, hypochromic anemia, polycythemia, prothrombin decreased, serum iron decreased</p><p><b>Postmarketing reports</b>: Agranulocytosis, disseminated intravascular coagulation, hemolytic anemia, hemolytic-uremic syndrome, neutropenia, pancytopenia, pure red cell aplasia, thrombocytopenic purpura, thrombotic thrombocytopenic purpura<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (64%), tremor (56%), paresthesia (40%), dizziness (19%), fatigue (16%)</p><p><b>Frequency not reported</b>: Amnesia, aphasia, convulsion, encephalopathy, hemorrhagic stroke, hypertonia, incoordination, monoparesis, myoclonus, nerve compression, nervousness, neuralgia, neuropathy, paralysis flaccid, psychomotor skills impaired, quadriparesis, seizures, somnolence, vertigo, writing impaired</p><p><b>Postmarketing reports</b>: Coma, dysarthria, posterior reversible encephalopathy syndrome (PRES), progressive multifocal leukoencephalopathy (PML), status epilepticus, quadriplegia, flaccid paralysis, hemiparesis, aphasia, syncope, carpal tunnel syndrome, nerve compression, mutism, dysarthria<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (64%) </p><p><b>Frequency not reported</b>: Abnormal dreams, agitation, anxiety, confusion, crying, depression, emotional lability, hallucinations, mental status changes, mood elevated, nightmares, psychosis, thinking abnormal</p><p><b>Postmarketing reports</b>: Mutism<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pain (63%), asthenia (54%), fever (48%)</p><p><b>Frequency not reported</b>: Abscess, accidental injury, chills, ear pain, fall, feeling abnormal, generalized edema, hernia, otitis media, sepsis, temperature intolerance, tinnitus<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Serum creatinine increased (45%), BUN increased (30%)</p><p><b>Frequency not reported</b>: BK nephropathy, hydronephrosis, renal failure, toxic nephropathy, tubular necrosis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Pleural effusion (36%), dyspnea (29%), atelectasis (28%), cough increased (18%), bronchitis (17%)</p><p><b>Frequency not reported</b>: Asthma, emphysema, hiccups, lung disorder, pharyngitis, pneumonia, pneumothorax, pulmonary edema, rhinitis, sinusitis, voice changes</p><p><b>Postmarketing reports</b>: Interstitial lung disease, pulmonary hypertension, lung infiltration, hiccups<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Liver function tests abnormal (36%)</p><p><b>Frequency not reported</b>: Cholangitis, cholestatic jaundice, GGT increased, granulomatous hepatitis, hepatitis, jaundice<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Pruritus (36%), rash (24%)</p><p><b>Frequency not reported</b>: Alopecia, cellulitis, hirsutism, photosensitivity, sweating</p><p><b>Postmarketing reports</b>: Hyperpigmentation<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract infection (34%), oliguria (19%)</p><p><b>Frequency not reported</b>: Albuminuria, bladder spasm, cystitis, dysuria, hematuria, nocturia, pyuria, urge incontinence, urinary frequency, urinary incontinence, urinary retention, vaginitis, hemorrhagic cystitis, urinary retention<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Cytomegalovirus infection (12%)</p><p><b>Frequency not reported</b>: Flu syndrome, graft versus host disease (acute and chronic)<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Postmarketing reports</b>: Epstein-Barr virus associated lymphoproliferative disorder, hepatosplenic T-cell lymphoma, leukemia, lymphoma, melanoma, post-transplant lymphoproliferative disorder (PTLD)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Arthralgia, generalized spasm, joint disorder, leg cramps, mobility decreased, myasthenia, myalgia, osteoporosis</p><p><b>Postmarketing reports</b>: Rhabdomyolysis, polyarthritis, pain in extremity including Calcineurin-Inhibitor Induced Pain Syndrome (CIPS)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity, Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Abnormal vision, amblyopia, blindness, optic atrophy, photophobia<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Prograf (tacrolimus)." Fujisawa, Deerfield, IL. </p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about Prograf (tacrolimus)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>26 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: calcineurin inhibitors</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Prograf &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Prograf Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Organ Transplant, Rejection Reversal</li>
<li>Organ Transplant, Rejection Prophylaxis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>